ArticleClinical diabetes : a publication of the American Diabetes Association2021

Rationale for the Use of Combination Injectable Therapy in Patients With Type 2 Diabetes Who Have High A1C (≥9%) and/or Long Duration (>8 Years): Executive Summary.

Vivian A Fonseca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.